Waka Ishida Selected Research

Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)

8/2013

Alarmins from corneal epithelial cells upregulate CCL11 and VCAM-1 in corneal fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Waka Ishida Research Topics

Disease

22	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 04/2022 - 01/2004
7	Inflammation (Inflammations) 01/2022 - 02/2011
6	Conjunctivitis 11/2021 - 10/2003
4	Hypersensitivity (Allergy) 04/2022 - 02/2005
3	Endophthalmitis (Ophthalmia) 01/2022 - 11/2019
3	Infections 01/2022 - 01/2016
3	Keratitis 08/2017 - 01/2012
3	Bacterial Infections (Bacterial Infection) 08/2017 - 12/2014
2	Glaucoma 01/2022 - 01/2019
2	Corneal Injuries 01/2022 - 08/2017
2	Necrosis 12/2014 - 07/2013
2	Dry Eye Syndromes (Dry Eye Syndrome) 12/2014 - 07/2013
2	Uveitis 07/2014 - 01/2005
2	Eosinophilia 08/2013 - 04/2011
1	Fibrosis (Cirrhosis) 01/2022
1	Cicatrix (Scar) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Retinal Detachment (Retinal Detachments) 11/2019
1	Atopic Dermatitis (Atopic Eczema) 07/2019
1	Hyperemia 01/2019
1	Ocular Hypertension (Glaucoma, Suspect) 01/2019
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2019
1	Rhinitis 11/2018
1	Psoriatic Arthritis 10/2018
1	Immediate Hypersensitivity 07/2013
1	Chronic Urticaria 01/2012
1	Atrophy 01/2012
1	Heart Failure 01/2012
1	Alopecia (Baldness) 01/2011
1	Contact Dermatitis (Eczema, Contact) 01/2011
1	Allergic Contact Dermatitis 01/2011
1	Asthma (Bronchial Asthma) 01/2008

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 04/2022 - 10/2003
9	CytokinesIBA 12/2017 - 02/2005
6	Ophthalmic Solutions (Eye Drops)IBA 04/2022 - 05/2006
4	AllergensIBA 11/2021 - 04/2005
3	Retinaldehyde (Retinal)IBA 01/2022 - 02/2011
3	VaccinesIBA 11/2021 - 05/2015
3	Therapeutic UsesIBA 11/2021 - 01/2012
3	InterleukinsIBA 08/2015 - 02/2005
2	OvalbuminIBA 04/2022 - 11/2014
2	AlarminsIBA 01/2022 - 08/2013
2	Peroxidase (Myeloperoxidase)IBA 01/2022 - 11/2019
2	Vancomycin FDA LinkGeneric 01/2021 - 11/2019
2	Interleukin-33IBA 12/2017 - 08/2015
2	LipopolysaccharidesIBA 08/2017 - 01/2016
2	Peptides (Polypeptides)IBA 01/2016 - 07/2014
2	rebamipideIBA 12/2014 - 07/2013
2	SecretagoguesIBA 12/2014 - 07/2013
2	Pharmaceutical PreparationsIBA 12/2014 - 07/2013
2	Messenger RNA (mRNA)IBA 12/2014 - 07/2014
2	MucinsIBA 12/2014 - 07/2013
2	HCEIBA 08/2013 - 07/2013
2	aluminum sulfate (alum)IBA 04/2011 - 08/2008
2	LigandsIBA 12/2008 - 08/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2022
1	Evans Blue (Blue, Evans)FDA Link 04/2022
1	CollagenIBA 01/2022
1	dupilumabIBA 07/2019
1	PeriostinIBA 04/2019
1	K-115IBA 01/2019
1	rho-Associated KinasesIBA 01/2019
1	Protein Kinase InhibitorsIBA 01/2019
1	epinastine FDA Link 01/2019
1	Anti-Allergic Agents (Antiallergic Agents)IBA 11/2018
1	Histamine Antagonists (Antihistamines)IBA 11/2018
1	Mast Cell StabilizersIBA 11/2018
1	Infliximab (Remicade)FDA Link 10/2018
1	PapainIBA 12/2017
1	lipopolysaccharide-binding proteinIBA 08/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2017
1	Thymic Stromal LymphopoietinIBA 08/2015
1	Interleukin-8 (Interleukin 8)IBA 12/2014
1	interstitial retinol-binding proteinIBA 07/2014
1	Interleukin-1 (Interleukin 1)IBA 08/2013
1	Chemokine CCL11IBA 08/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2013
1	Phosphotransferases (Kinase)IBA 07/2013
1	Member 14 Tumor Necrosis Factor ReceptorsIBA 02/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2012
1	Olopatadine Hydrochloride (Patanol)FDA Link 01/2012
1	Tuberculin (PPD)IBA 01/2011
1	4-phenylenediamine (p-phenylenediamine)FDA Link 01/2011
1	Hair DyesIBA 01/2011
1	staphylococcal enterotoxin BIBA 09/2010
1	alpha-galactosylceramideIBA 09/2008
1	Interleukin-17 (Interleukin 17)IBA 01/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2006
1	Integrin alpha4beta1 (VLA-4)IBA 04/2006
1	ChemokinesIBA 04/2006
1	OX40 LigandIBA 02/2006

Therapy/Procedure

5	Immunotherapy 11/2021 - 11/2014
4	Oral Administration 11/2021 - 04/2013
2	Phage Therapy 01/2021 - 11/2019
1	Filtering Surgery 01/2022
1	Therapeutics 01/2021
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 01/2019
1	Contact Lenses 12/2017